학술논문

Comparative Efficacy, Quality of Life, and Safety/Tolerability of Atogepant and Rimegepant in Migraine Prevention: A Matching-Adjusted Indirect Comparison
Document Type
Journal
Source
CEPHALALGIA; SEP 2023, 43 1supp, p258-p260, 3p. Supplement: 1
Subject
Language
English
ISSN
14682982